The Gist Healthcare Podcast

A Senate committee votes to both investigate Steward Health Care and subpoena its CEO to testify. The American Medical Association and other physician groups implore Congress to act on physician Medicare pay. And the Health and Human Services Department reorganizes its technology functions to better address AI and cyber threats in healthcare. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Ascension sells 9 Illinois hospitals to Prime Healthcare. New analysis shows that Medicare Advantage accounts for a growing percentage of hospital inpatient care. And a study finds that more new GLP-1 prescriptions were written for people with obesity than for those with Type 2 diabetes in recent years. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A federal judge refuses to block the FTC’s noncompete ban, deviating from a separate ruling on the ban earlier this month. Humana announces it will take over 23 former Walmart Health sites. And Steward Health Care finds buyers for some of its hospitals, but fails to drum up any qualified bidders for others. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A House committee investigation finds PBMs steer patients toward pricier drugs ahead of a Congressional hearing on the issue. A pharmacy group and dozens of providers sue Change Healthcare. And CMS sets limits on ACA marketplace brokers to rein in unauthorized changes to beneficiaries’ plans. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A global tech outage highlights vulnerabilities across the U.S. economy, including in healthcare delivery. U.S. health officials are investigating a deadly listeria outbreak tied to deli meat. And Vermont becomes the latest state to sue PBMs over allegations of driving up prescription drug prices. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Ardent Health goes public... raising around $192 million dollars in its IPO. A summer COVID wave spreads across the US. And more states look to curb prescription drug costs with public affordability boards. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The FDA plans to launch a rare disease center to streamline its policies and methods for evaluating experimental drugs. Drugmaker Roche sees positive results from an early-stage trial of its obesity pill. And a new study finds that bone marrow transplant patients may not need a perfect donor match. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Steward Health Care confirms it is under federal investigation. A judge denies an extension for Georgia’s new Medicaid plan, the only in the nation with a work requirement. And new CDC data finds that Americans with disabilities are more likely to report long COVID symptoms. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The House Appropriations Committee is requesting that the FDA holds off on regulating laboratory developed tests. A recent report finds that private equity-backed providers account for less than 4 percent of the U.S. provider market by revenue. And a new study links semaglutide to lower risk for both dementia and nicotine use. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

In its first No Surprises audit, CMS finds some noncompliance with CVS-owned Aetna. State attorneys general warn of consumer impacts from the Change Healthcare cyberattack. And a report says about 7 percent of U.S. adults have had long COVID. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The Senate unanimously passes a bill that cracks down on drug patent practices. House GOP leaders demand regulatory reviews from federal agencies, including the Health and Human Services Department, following the Supreme Court’s Chevron decision. And a new study links alcohol to more than a half dozen cancers. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

CMS proposes a nearly 3 percent Medicare physician pay cut in 2025. The Office of the National Coordinator for Health Information Technology releases its proposed rule to improve data sharing. And a new observational study compares weight loss between adults on tirzepatide versus semaglutide. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Sanford Health and Marshfield Clinic Health System are exploring a combination. Medicare proposes a 2.6 percent pay increase for hospital outpatient departments and ambulatory surgical centers. And dozens of Medicare Advantage plans get higher star ratings after CMS recalculations. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

An interim FTC report scrutinizes pharmacy benefit managers. A proposed federal cybersecurity rule draws criticism from the healthcare industry. And dozens of health systems see their credit ratings drop. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

In two separate rulings, federal judges partially block both the FTC’s noncompete ban and a federal gender nondiscrimination rule. Massachusetts lawmakers target real estate investment trusts in a sweeping healthcare bill. And the FDA approves Eli Lilly’s early Alzheimer’s treatment. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

How the U.S. Supreme Court’s Chevron ruling could impact healthcare. Two decades on, the U.S. has made little progress on addressing health inequities... according to a new report. And HHS and the FBI warn the healthcare sector of certain types of cyberattacks, including phishing schemes. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The Congressional Budget Office projects that the nation’s uninsured rate will rise to nearly 9 percent by 2034. More nurse practitioners are moving into specialty care. And early results from a large clinical trial show a new drug may provide total protection against HIV. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The UAB Health System Authority signs an agreement to acquire Ascension St. Vincent. Missouri joins a growing list of states passing laws to expand 340B drug access. And Teva Pharmaceuticals launches first generic GLP-1 drug in the U.S. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The U.S. Surgeon General declares gun violence a public health crisis. The U.S. Supreme Court agrees to hear a case challenging Tennessee’s ban on gender-affirming care for minors. And HHS finalizes a rule that sets penalties for providers blocking the free exchange of electronic health record data. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A federal appeals court largely upholds the ACA’s free preventive services mandate. A new study finds that a popular GLP-1 drug may help treat sleep apnea. And more states are expanding Medicaid coverage to hospital at home care. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Risant Health announces its plan to acquire Cone Health. The WHO warns about fake versions of the diabetes drug Ozempic. And federal actuaries project that U.S. healthcare spending will hit nearly $8 trillion by 2032. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The U.S. Supreme Court rejects a case challenging the FDA’s policies on mifepristone. Ascension says protected health data might have been exposed in its recent cyberattack. And the director of CMS’ Innovation Center testifies before a Congressional subcommittee. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The White House teams up with Big Tech to help boost rural hospital cybersecurity.  Insurers get another court win with a recent Medicare Advantage star ratings ruling. And Walgreens-owned CityMD agrees to pay $12 million for alleged COVID payment fraud. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

FDA advisors unanimously recommend approval of Eli Lilly’s Alzheimer’s drug donanemab. The Biden administration proposes a rule to ban medical debt from consumer credit reports. And the U.S. Supreme Court will review a case on Medicare Disproportionate Share Hospital payments. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Moderna reports positive results from its COVID-flu combined vaccine late-stage trial. A new Florida law allows doctors to perform c-sections outside of hospitals. And the American Cancer Society aims to enroll 100,000 Black women in an ambitious new cancer study.  That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Kroger Health expands its weight-management program to include GLP-1 treatments. Cases of whooping cough more than double in the U.S. And new research links 200-plus symptoms to long COVID. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Oregon Health & Science University and Legacy Health sign an agreement to merge. A judge rejects an FTC request to block Novant Health’s acquisition of two CHS hospitals. And a group of Senators introduce legislation to overturn the nursing home staffing mandate. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

An FDA advisory panel recommended against using ecstasy as a treatment for PTSD. A Congressional subcommittee weighs reforming the 340B Drug Pricing Program. And a new study reports that drug shortages are more frequent and last longer. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

SCAN Health Plan wins its Medicare Advantage star ratings lawsuit against CMS. The University of Pittsburgh Medical Center acquires Washington Health System. And a new study highlights racial and ethnic disparities within Medicaid renewal procedural issues. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

HHS clarifies that Change Healthcare is responsible for data breach notifications – not individual providers. Structure Therapeutics reports that its oral GLP-1 drug led to weight loss in two small studies. And the FDA approves Moderna’s mRNA RSV vaccine for adults over 60. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Novartis sues to block a Maryland law concerning contract pharmacies and the 340B drug pricing program. Hospitals find fault with CMS’ proposed Transforming Episode Accountability Model. And a new study examines the impact of cyberattacks on nearby unattacked hospitals. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Dollar General and Doc-Go halt their mobile health clinic program. The American Clinical Laboratory Association sues over the FDA’s final rule regulating laboratory-developed tests. And a new report says NIH-funded clinical trials often don't meet their racial & gender diversity enrollment goals. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Hospital groups join a multi-sector plea to the FTC to delay a new ban on noncompetes. A new study ties weight-loss drug Wegovy to reduced risk for alcohol use disorder. And drugmaker Eli Lilly says it will spend billions of dollars to expand its GLP-1 production capacity. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Recent congressional hearings zero in on healthcare consolidation. Nursing home trade groups sue over the Biden Administration’s new staffing mandate. And a new CDC analysis shows that stroke rates have been on the rise. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Novo Nordisk reports that its GLP-1 drug Ozempic could help treat kidney disease. An advisory panel recommends the FDA approve Guardant Health’s colon cancer blood test. And Louisiana lawmakers vote to reclassify abortion pills as controlled dangerous substances. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Another human bird flu case linked to dairy cows is reported in Michigan. Drugmakers win a court victory amid the legal battle over the 340-B Drug Pricing Program. And Los Angeles County launches a new plan for tackling medical debt. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The Senate Judiciary Committee accuses drugmakers of abusing the patent system, causing prescription drug prices to soar. Patients denied emergency care can now file complaints directly to the Centers for Medicare and Medicaid Services. And a new study reports that many Americans are quitting weight-loss drugs before their health benefits kick in. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

An Health and Human Services agency announces a new cybersecurity protection program for hospitals. The Senate Finance Committee weighs in on Medicare physician payment reform. And UnitedHealth’s pharmacy benefit manager announces a new drug pricing model. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A federal transparency rule on direct-to-consumer prescription drug advertising takes effect. Telehealth company Hims & Hers Health announced it will offer compounded GLP-1 medications. And the Centers for Disease Control and Preventions ends its free COVID vaccine program for the under and uninsured this summer. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The U.S. Justice Department starts the formal process to reclassify marijuana as a less dangerous drug. The CDC warns about a possible resurgence of m-pox. And the number of hospital-at-home programs is increasing, even as the future of Medicare reimbursement remains uncertain. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The FDA approves self-collection screening for HPV. Eli Lilly reports promising results for its weekly insulin drug. And the country’s only tribal-affiliated medical school graduates its first class of physicians. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Jefferson Health and Lehigh Valley Health Network sign an agreement to merge. Preliminary data shows a drop in overdose deaths in 2023. Marking the first decline in years. And Novo Nordisk will test whether its weight-loss drugs can help people with alcohol-related liver disease. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A federal judge partially dismisses a lawsuit accusing a private equity firm of suppressing competition in the anesthesia market. New analyses of clinical trial results show Wegovy users kept weight off for years. And U.S. News and World Report puts out its first ambulatory surgery center ratings. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Ascension confirms its ongoing cyber event was a ransomware attack. CMS extends Medicaid unwinding waivers for states into 2025. And MultiPlan faces another lawsuit accusing it of colluding with insurers on provider reimbursement rates. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The Biden Administration is planning to issue cybersecurity standards for hospitals. The DOJ forms a new task force focused on anti-competitive behavior in healthcare. And a new survey shows most Americans want Medicare to cover weight-loss drugs. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Nonprofit health system Ascension reports a cyber incident. A U.S. House committee advances a bill extending telehealth and hospital-at-home care. And CMS proposes a new mandatory model for kidney transplants. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Steward Health Care puts its hospitals up for sale after its bankruptcy filing. The human risk for bird flu remains low in the US. But 2 human infections raise questions about pandemic readiness. And the Biden Administration faces a lawsuit over a rule barring gender identity discrimination in healthcare. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Walgreens will partner with a major drugmaker on a GLP-1 clinical trial. Oregon is helping Medicaid patients prepare for the health impacts of climate change. And new long-acting HIV therapies could change prevention and treatment. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Hospital operator Steward Health Care files for Chapter 11 bankruptcy. An effort to expand Medicaid in Mississippi collapses. And MultiPlan faces mounting legal troubles and potential federal scrutiny over allegations of health care price fixing. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

HHS expands access to the ACA health insurance market to Dreamers lacking coverage. Pregnancy-related deaths are on the decline. But some physicians still have concerns. And data shows that community health centers are taking a hit from the Medicaid redetermination process. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.